Showing results (61-70 of 420) with videos related to
Sort By:
Pageof 42
Experimental Neurology|April 11, 2017
Human stem cell modeling in neurofibromatosis type 1 (NF1)Michelle L Wegscheid, Corina Anastasaki, David H GutmannCurrent Topics in Developmental Biology|February 8, 2011
Rethinking pediatric gliomas as developmental brain abnormalitiesNikkilina R Crouse, Sonika Dahiya, David H GutmannPediatric Blood & Cancer|October 20, 2017
Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insightsSoumen Khatua, David H Gutmann, Roger J PackerBrain Pathology (Zurich, Switzerland)|May 26, 2005
Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 casesArie Perry, Eriks A Lusis, David H GutmannAnnual Review of Pathology|January 31, 2017
Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1Courtney L Monroe, Sonika Dahiya, David H GutmannNeuro-Oncology|January 1, 2017
Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunctionJoseph A Toonen, Yu Ma, David H GutmannProceedings of the National Academy of Sciences of the United States of America|December 16, 2004
Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-LRong Rong, Xiaoling Tang, David H Gutmann, et al.Oncogene|January 16, 2004
Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene functionEzequiel I Surace, Carrie A Haipek, David H GutmannGlia|December 7, 2015
Pediatric gliomas as neurodevelopmental disordersSuzanne J Baker, David W Ellison, David H GutmannDevelopmental Medicine and Child Neurology|August 29, 2017
Neurodevelopmental disorders in children with neurofibromatosis type 1Alecia C Vogel, David H Gutmann, Stephanie M MorrisPageof 42